Serplulimab (Anti-PDCD1 / PD-1 / CD279)

Serplulimab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody directed against the negative immunoregulatory human cell receptor programmed cell death protein 1 (PD-1; PDCD1; CD279), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 145.5 kD.

• Supplier: Selleck Chemicals
• Product #: A2381
• Sku #: A2381-1mg*25